Abstract:BACKGROUND: Several epidemiological investigations demonstrated that maternal arsenic (As) exposure elevated risk of fetal growth restriction (FGR), but the mechanism remains unclear. OBJECTIVES: This study aimed to investigate the effects of gestational As exposure on placental and fetal development and its underlying mechanism. METHODS: Dams were exposed to 0.15, 1.5, and 15 mg/L NaAsO2 throughout pregnancy via drinking water. Sizes of fetuses and placentas, placental histopathology, and glycogen content were measured. Placental RNA sequencing was conducted. Human trophoblasts were exposed to NaAsO2 (2 lM) to establish an in vitro model of As exposure. The mRNA stability and protein level of genes identified through RNA sequencing were measured. N6-Methyladenosine (m6A) modification was detected by methylated RNA immunoprecipitation-quantitative real-time polymerase chain reason (qPCR). The binding ability of insulin-like growth factor 2 binding protein 2 to the gene of interest was detected by RNA-binding protein immunoprecipitation-qPCR. Intracellular S-adenosylmethionine (SAM) and methyltransferase activity were determined by liquid chromatography- tandem mass spectrometry (LC-MS/MS) and colorimetry, respectively. In vitro As+3 methyltransferase (As3MT) knockdown or SAM supplementation and in vivo folic acid (FA) supplementation were used to evaluate the protective effect. A case-control study verified the findings. RESULTS: Sizes of fetuses (exposed to 1.5 and 15 mg/L NaAsO2) and placentas (exposed to 15 mg/L NaAsO2) were lower in As-exposed mice. More glycogen+ trophoblasts accumulated and the expression of markers of interstitial invasion was lower in the 15 mg/L NaAsO2-exposed mouse group in comparison with control. Placental RNA sequencing identified cysteine-rich angiogenic inducer 61 (Cyr61) as a candidate gene of interest. Mechanistically, mice and cells exposed to As had lower protein expression of CYR61, and this was attributed to a lower incidence of Cyr61 m6A. Furthermore, cells exposed to As had lower methyltransferase activity, suggesting that this could be the mechanism by which Cyr61 m6A was affected. Depletion of intracellular SAM, a cofactor for m6A methyltransferase catalytic domain, partially contributed to As-induced methyltransferase activity reduction. Either As3MT knockdown or SAM supplementation attenuated As-induced Cyr61 m6A down-regulation. In mice, FA supplementation rescued As-induced defective trophoblastic invasion and FGR. In humans, a negative correlation between maternal urinary As and plasma CYR61 was observed in infants who were small for gestational age. DISCUSSION: Using in vitro and in vivo models, we found that intracellular SAM depletion-mediated Cyr61 m6A down-regulation partially contributed to As-induced defective trophoblastic invasion and FGR. https://doi.org/10.1289/EHP12207

Mechanism of arsenite toxicity in embryonic stem cells

Effect of Arsenic Compounds on the in Vitro Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes

Arsenic Exposure During Juvenile and Puberty Significantly Affected Reproductive System Development of Female SD Rats

Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell

In utero exposure to arsenite contributes to metabolic and reproductive dysfunction in male offspring of CD-1 mice

Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation.

Low-Dose Arsenic Trioxide Modulates the Differentiation of Mouse Embryonic Stem Cells.

Prenatal arsenic exposure alters keratinocyte stem cell fate through persistent activation of IGF2R‐MAPK cascade leading to aggravated skin carcinogenesis in mice offspring

Toxicity of inorganic arsenic and its metabolites on haematopoietic progenitors “in vitro”: Comparison between species and sexes

Intergenerational arsenic exposure on the mouse epigenome and metabolic physiology

Arsenite exposure disturbs maternal-to-zygote transition by attenuating H3K27ac during mouse preimplantation development

Arsenic, Stem Cells, and the Developmental Basis of Adult Cancer.

Intrauterine exposure of mice to arsenite induces abnormal and transgenerational glycometabolism

Effects of Gestational Arsenic Exposures on Placental and Fetal Development in Mice: The Role of<i> Cyr61</i> m<SUP>6</SUP>A

Chronic Low Dose Arsenic Exposure Preferentially Perturbs Mitotic Phase of the Cell Cycle

Arsenic exposure during porcine oocyte maturation negatively affects embryonic development by triggering oxidative stress-induced mitochondrial dysfunction and apoptosis

Developmental exposure to arsenic reduces anxiety levels and leads to a depressive-like behavior in female offspring rats: molecular changes in the prefrontal cortex

Transcriptomic Effects of Low-Dose Inorganic Arsenic Exposure on Murine Bone Marrow-Derived Macrophages

Differential Sensitivities of Bone Marrow, Spleen and Thymus to Genotoxicity Induced by Environmentally Relevant Concentrations of Arsenite

Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells

Arsenide-induced Cytotoxicity to Human Embryonic Kidney 293 Cells